Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- befree-2016 importedOn "2016-02-19" NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_assertion wasGeneratedBy ECO_0000203 NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_assertion wasDerivedFrom befree-2016 NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_assertion SIO_000772 23607916 NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_assertion evidence source_evidence_literature NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.
- NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_assertion description "[Because the EGFR inhibitor cetuximab is a standard HNSCC therapy, we tested its efficacy and observed a wide spectrum of efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1071420.RAcA6WOIs7O3h2cJYmYa-fxYlV_B9lme-YPaYScJzTb7w130_provenance.